The Mesothelioma Center News
Mesothelioma Specialist Brings HIPEC Expertise to Stanford
- by Tim Povtak
- Treatment & Doctors
- May 26, 2020
Surgical oncologist and mesothelioma specialist Dr. Byrne Lee spent close to a decade in Southern California, building a well-respected peritoneal surface malignancy program at City of Hope Comprehensive Cancer…
Read More
Johnson & Johnson Ends Talc-Based Baby Powder Sales in US, Canada
- by Tim Povtak
- Asbestos Exposure & Bans
- May 20, 2020
Johnson & Johnson announced Tuesday that it will stop selling its iconic, talc-based baby powder, the target of thousands of lawsuits claiming that its talc was contaminated with asbestos, which…
Read More
New Tests Find Asbestos-Contaminated Talc in Eyeshadow
- by Tim Povtak
- Asbestos Exposure & Bans
- May 19, 2020
The Scientific Analytical Institute in Greensboro, North Carolina, recently uncovered asbestos-contaminated talc in two new eyeshadow makeup products sold online on sites like Amazon and eBay. Its findings were the…
Read More
Libby Protects Those with Asbestos Disease from COVID-19
- by Tim Povtak
- Asbestos Exposure & Bans
- May 13, 2020
No town in America has a higher percentage of asbestos-related lung disease — and resulting respiratory issues — than Libby, Montana, making its population uniquely vulnerable to the COVID-19…
Read More
Report Finds Asbestos, Other Risks in Military Family Housing
- by Tim Povtak
- Asbestos Exposure & Bans
- May 11, 2020
U.S. military families around the world are living in government-owned and -operated housing containing serious health and safety risks, according to the most recent report by the Department of Defense…
Read More
Latest Clinical Trial for Pleural Mesothelioma Opens in Georgia
- by Tim Povtak
- Research & Clinical Trials
- May 6, 2020
Dr. Nagla Abdel Karim of the Georgia Cancer Center has seen the effectiveness of cabozantinib with certain types of thyroid, kidney and liver cancers. She believes it may also work…
Read More
Mesothelioma Drug Combination Continues to Show Promise
- by Tim Povtak
- Research & Clinical Trials
- May 4, 2020
Pharmaceutical giant Bristol Myers Squibb continues to tout its immunotherapy combination of Opdivo and Yervoy for first-line treatment of patients with pleural mesothelioma cancer. Bristol Myers Squibb recently announced…
Read More
EPA Asbestos Review Delayed Due to COVID-19 Pandemic
- by Tim Povtak
- Asbestos Exposure & Bans
- Apr 23, 2020
The U.S. Environmental Protection Agency postponed indefinitely a peer review of the recent asbestos risk evaluation draft done by its Science Advisory Committee on Chemicals. A peer review virtual meeting…
Read More
UK Oncologist Proposes Novel Treatment for Mesothelioma
- by Tim Povtak
- Treatment & Doctors
- Apr 22, 2020
Medical oncologist Dr. Angus Dalgleish never did like standard of care treatment for pleural mesothelioma cancer, even when he reluctantly recommended it in the past. He believes now there…
Read More
Duke Study Challenges Mesothelioma Chemotherapy Practices
- by Tim Povtak
- Treatment & Doctors
- Apr 16, 2020
Neoadjuvant chemotherapy — often used before aggressive surgery — has shown no definitive survival benefit for patients with pleural mesothelioma cancer, according to a recent study at the Duke University…
Read More
